Correlation Between Ibio and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ibio and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ibio Inc and ZyVersa Therapeutics, you can compare the effects of market volatilities on Ibio and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and ZyVersa Therapeutics.
Diversification Opportunities for Ibio and ZyVersa Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ibio and ZyVersa is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Ibio i.e., Ibio and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Ibio and ZyVersa Therapeutics
Given the investment horizon of 90 days Ibio Inc is expected to generate 1.42 times more return on investment than ZyVersa Therapeutics. However, Ibio is 1.42 times more volatile than ZyVersa Therapeutics. It trades about 0.02 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 608.00 in Ibio Inc on September 1, 2024 and sell it today you would lose (314.00) from holding Ibio Inc or give up 51.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ibio Inc vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Ibio Inc |
| ZyVersa Therapeutics |
Ibio and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ibio and ZyVersa Therapeutics
The main advantage of trading using opposite Ibio and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |